|
Q4 2021
Filed on Feb 02, 2022
|
12,156
|
$21.45 - $21.68
$261K - $264K
|
|
|
Q4 2021
Filed on Feb 02, 2022
|
3,263
|
N/A
|
|
|
Q4 2021
Filed on Feb 02, 2022
|
12,281
|
$4.21 - $7.61
$51.7K - $93.5K
|
|
|
Q4 2021
Filed on Feb 02, 2022
|
11,473
|
$7.57 - $22.56
$86.9K - $259K
|
|
|
Q4 2021
Filed on Feb 02, 2022
|
23,013
|
$1.63 - $3.41
$37.5K - $78.5K
|
|
|
Q4 2021
Filed on Feb 02, 2022
|
18,163
|
$2.32 - $6.75
$42.1K - $123K
|
|
|
Q4 2021
Filed on Feb 02, 2022
|
23,366
|
$1.04 - $2.1
$24.3K - $49.1K
|
|
|
Q4 2021
Filed on Feb 02, 2022
|
38,037
|
$3.37 - $7.91
$128K - $301K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
36,986
|
N/A
|
|
Alexion Pharmaceuticals Inc
|
Q3 2021
Filed on Nov 12, 2021
|
2,163
|
N/A
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
10,000
|
$1.33 - $1.77
$13.3K - $17.7K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
46,422
|
$63.43 - $85.2
$2.94M - $3.96M
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
22,987
|
$18.06 - $26.95
$415K - $619K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
31,022
|
$1.6 - $2.3
$49.6K - $71.4K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
186,360
|
$5.94 - $7.32
$1.11M - $1.36M
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
106,392
|
N/A
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
4,088
|
$47.75 - $62.35
$195K - $255K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
585,840
|
N/A
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
10,000
|
$1.23 - $2.69
$12.3K - $26.9K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
2,874
|
$196.16 - $208.81
$564K - $600K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
7,471
|
$32.45 - $34.78
$242K - $260K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
9,736
|
N/A
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
6,202
|
$53.5 - $68.63
$332K - $426K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
13,500
|
$3.44 - $4.24
$46.4K - $57.2K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
38,149
|
$9.44 - $9.83
$360K - $375K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
3,161
|
N/A
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
4,048
|
$46.51 - $53.1
$188K - $215K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
13,737
|
$65.29 - $72.2
$897K - $992K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
4,667
|
$43.34 - $45.98
$202K - $215K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
2,554
|
$239.54 - $265.23
$612K - $677K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
5,035
|
$36.3 - $40.37
$183K - $203K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
5,700
|
$42.05 - $52.34
$240K - $298K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
25,836
|
$19.38 - $20.78
$501K - $537K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
1,115
|
$156.91 - $215.29
$175K - $240K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
8,736
|
$39.27 - $72.94
$343K - $637K
|
|
Maxim Integrated Prods Inc
|
Q3 2021
Filed on Nov 12, 2021
|
3,184
|
N/A
|
|
Catabasis Pharmaceuticals In
|
Q3 2021
Filed on Nov 12, 2021
|
61,500
|
N/A
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
10,200
|
$12.01 - $12.65
$123K - $129K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
11,636
|
$11.24 - $21.0
$131K - $244K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
13,005
|
$29.04 - $29.86
$378K - $388K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
12,600
|
$13.07 - $13.46
$165K - $170K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
3,935
|
$105.87 - $120.59
$417K - $475K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
7,708
|
$23.94 - $27.67
$185K - $213K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
8,934
|
$78.92 - $114.41
$705K - $1.02M
|
|
Tortoise Essential Assets In
|
Q3 2021
Filed on Nov 12, 2021
|
36,491
|
N/A
|
|
Ivy High Income Opportunitie
|
Q3 2021
Filed on Nov 12, 2021
|
16,100
|
N/A
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
5,486
|
$52.9 - $63.75
$290K - $350K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
6,500
|
$91.91 - $110.37
$597K - $717K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
1,035
|
N/A
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
17,775
|
$21.52 - $21.61
$383K - $384K
|
|